The campaign to engage Trump Administration decision makers and Capitol Hill on plans to restart the Competitive Bidding Program for DME continues without pause.
Medicare Advantage has increasingly been criticized for waste, fraud, and abuse. A key issue lies in how the government reimburses these private insurers.